AKRO - Akero Therapeutics prices $220M offering
2023-05-17 05:31:57 ET
- Clinical-stage company developing transformational treatments for patients with serious metabolic diseases, Akero Therapeutics ( NASDAQ: AKRO ) prices an underwritten offering of 5.24M shares at a price of $42.00 per share.
- Total gross proceeds of ~$220M.
- Closing expected on May 19, 2023.
For further details see:
Akero Therapeutics prices $220M offering